Codexis (CDXS) Retained Earnings (2010 - 2026)
Codexis (CDXS) posted quarterly Retained Earnings of -$615.5 million for Q1 2026, down 197.22% year-over-year from $633.1 million in Q1 2025, and down 193.64% quarter-over-quarter from $657.3 million in Q4 2025.
Codexis (CDXS) Retained Earnings (2010 - 2026) Analysis & Trends
Codexis' Retained Earnings history runs 17 years deep, the most recent figure standing at -$615.5 million for Q1 2026.
- In Q1 2026, Retained Earnings fell 197.22% year-over-year to -$615.5 million; the TTM figure through Mar 2026 stood at -$615.5 million (down 197.22% YoY), while the FY2025 annual figure was $657.3 million, up 1263923.08% from the prior year.
- Retained Earnings for Q1 2026 stood at -$615.5 million, down from $657.3 million in the prior quarter.
- The five-year high for Retained Earnings was $657.3 million in Q4 2025, with the low at -$615.5 million in Q1 2026.
- The 5-year median for Retained Earnings is $126000.0 (2024), against an average of $115.7 million.
- The sharpest annual moves came in 2025 and 2026: Retained Earnings jumped 1263923.08% in 2025, then slumped 197.22% in 2026.
- Codexis' Retained Earnings stood at $566.1 million in 2022, then increased by 3.19% to $584.1 million in 2023, then slumped by 99.99% to $52000.0 in 2024, then surged by 1263923.08% to $657.3 million in 2025, then plunged by 193.64% to -$615.5 million in 2026.
- Business Quant data shows CDXS's Retained Earnings at -$615.5 million in Q1 2026, $657.3 million in Q4 2025, and $654.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.89 Bn | 131.04 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 86.05 Bn | 78.06 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.38 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 55.46 Bn | 50.32 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 27.70 Bn | 9.30 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | 4.38 Bn |
| 10 | Codexis | 149.33 Mn | 94.41 Mn | 11.40 Mn | 660.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 660.45 Mn |
| Mar 31, 2026 | -615.48 Mn |
| Dec 31, 2025 | 657.29 Mn |
| Sep 30, 2025 | 654.90 Mn |
| Jun 30, 2025 | -3,000.00 |
| Mar 31, 2025 | 633.10 Mn |
| Dec 31, 2024 | 52,000.00 |
| Sep 30, 2024 | 126,000.00 |
| Jun 30, 2024 | -531.79 Mn |
| Mar 31, 2024 | -509.04 Mn |
| Dec 31, 2023 | 584.14 Mn |
| Sep 30, 2023 | 581.84 Mn |
| Jun 30, 2023 | 579.56 Mn |
| Mar 31, 2023 | 569.92 Mn |
| Dec 31, 2022 | 566.08 Mn |
| Sep 30, 2022 | -408.69 Mn |
| Jun 30, 2022 | -398.69 Mn |
| Mar 31, 2022 | -396.05 Mn |
| Dec 31, 2021 | -387.70 Mn |
| Sep 30, 2021 | 546.56 Mn |